Eventide Asset Management - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 226 filers reported holding BEAM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,285,708
-57.1%
261,360
-43.1%
0.11%
-54.4%
Q2 2023$14,662,352
+4.3%
459,2030.0%0.25%
-3.9%
Q1 2023$14,060,796
+34.6%
459,203
+72.0%
0.26%
+25.2%
Q4 2022$10,443,348
-17.9%
267,0250.0%0.21%
-17.6%
Q3 2022$12,721,000267,0250.25%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders